Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. (Q28288666)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 June 2017

Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. (English)

1 reference

Europe PubMed Central

24 June 2017

0 references

0 references

Shunsuke Kawamura

object named as

Shunsuke Kawamura

2

0 references

author name string

Junichi Kikuta

1

1 reference

Europe PubMed Central

24 June 2017

Fumie Okiji

3

1 reference

Europe PubMed Central

24 June 2017

Mai Shirazaki

4

1 reference

Europe PubMed Central

24 June 2017

Sadaoki Sakai

5

1 reference

Europe PubMed Central

24 June 2017

Hitoshi Saito

6

1 reference

Europe PubMed Central

24 June 2017

Masaru Ishii

7

1 reference

Europe PubMed Central

24 June 2017

language of work or name

0 references

publication date

8 April 2013

1 reference

Europe PubMed Central

24 June 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

24 June 2017

110

1 reference

Europe PubMed Central

24 June 2017

17

1 reference

Europe PubMed Central

24 June 2017

7009-7013

1 reference

Europe PubMed Central

24 June 2017

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3637769/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Bone resorption by osteoclasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

20 March 2017

Genetic regulation of osteoclast development and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

7 April 2017

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

7 April 2017

Vitamin D and cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Eldecalcitol: a review of its use in the treatment of osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Vitamin D, disease and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Quantifying cellular interaction dynamics in 3D fluorescence microscopy data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Vitamin D and human health: lessons from vitamin D receptor null mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Reaching a genetic and molecular understanding of skeletal development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

New clues about vitamin D functions in the nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

Structure-function relationships in the vitamin D endocrine system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

29 September 2017

A Novel Synthetic Vitamin D3 Analogue, 2-Beta-(3-Hydroxypropoxy)-Calcitriol (ED-71): Its Biological Activities and Pharmacological Effects on Calcium Metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

2 June 2018

Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637769

27 November 2018

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1218799110

21 January 2018

Vitamin D and bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.1218799110

1 reference

Europe PubMed Central

24 June 2017

2013PNAS..110.7009K

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Europe PubMed Central

24 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28288666&oldid=1768781134"